REQUEST A DEMO
Total
USD $0.00
Search more companies

"Largo" Sp. z o.o. (Poland)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Lessors of Real Estate | Educational Services | General Medical and Surgical Hospitals
Full name: "Largo" Sp. z o.o. Profile Updated: October 03, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Largo Sp. z o.o is a medical company specializing in breast cancer diagnosis and offering digital diagnostics technology, including three-dimensional digital mammography with tomosynthesis and elastography for the assessment of chronic liver diseases. They also provide USG slinacks for the assessment of mucous glands. The company offers oncological surgical benefits.

Headquarters
Ul. Kakolewska 13C
Grodzisk Wielkopolski; Wielkopolskie; Postal Code: 62-065

Contact Details: Purchase the "Largo" Sp. z o.o. report to view the information.

Website: http://www.largo-mammografia.pl

Basic Information
Total Employees:
Purchase the "Largo" Sp. z o.o. report to view the information.
Registered Capital:
Purchase the "Largo" Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the "Largo" Sp. z o.o. report to view the information.
Incorporation Date:
May 13, 2003
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after "Largo" Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
30.1%
Total operating revenue
29.81%
Operating profit (EBIT)
45.73%
EBITDA
37.81%
Net Profit (Loss) for the Period
29.89%
Total assets
8.46%
Total equity
19.17%
Operating Profit Margin (ROS)
2.41%
Net Profit Margin
-0.03%
Return on Equity (ROE)
5.77%
Debt to Equity Ratio
-4.22%
Quick Ratio
0.49%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?